SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-18-006050
Filing Date
2018-04-02
Accepted
2018-04-02 16:02:44
Documents
90
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K dffn20171231_10k.htm 10-K 1698250
2 EXHIBIT 10.5 ex_108103.htm EX-10.5 63257
3 EXHIBIT 21.1 ex_108104.htm EX-21.1 6749
4 EXHIBIT 23.1 ex_108150.htm EX-23.1 3461
5 EXHIBIT 31.1 ex_108105.htm EX-31.1 14990
6 EXHIBIT 31.2 ex_108106.htm EX-31.2 15017
7 EXHIBIT 32.1 ex_108107.htm EX-32.1 6681
14 kpmgsig.jpg GRAPHIC 2562
15 a6.jpg GRAPHIC 18202
16 a5.jpg GRAPHIC 82331
17 a4.jpg GRAPHIC 25029
18 a3.jpg GRAPHIC 30903
19 a2.jpg GRAPHIC 40638
20 a1.jpg GRAPHIC 62891
  Complete submission text file 0001437749-18-006050.txt   7619866

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT dffn-20171231.xml EX-101.INS 1161203
9 XBRL TAXONOMY EXTENSION SCHEMA dffn-20171231.xsd EX-101.SCH 74635
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20171231_cal.xml EX-101.CAL 49982
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20171231_def.xml EX-101.DEF 618167
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20171231_lab.xml EX-101.LAB 458429
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20171231_pre.xml EX-101.PRE 629841
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37942 | Film No.: 18728866
SIC: 2834 Pharmaceutical Preparations